---
figid: PMC5692579__pnas.1712612114fig04
figtitle: Signaling pathways involved in the antihypertrophic effects of GHRH in vitro
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Sus scrofa
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC5692579
filename: pnas.1712612114fig04.jpg
figlink: /pmc/articles/PMC5692579/figure/fig04/
number: F4
caption: 'Signaling pathways involved in the antihypertrophic effects of GHRH in vitro.
  Antihypertrophic actions of GHRH include GHRH-R–dependent activation of the AC/cAMP/PKA
  pathway (Left). GHRH inhibits PE-induced signaling by blocking the α1-AR/Gq pathway
  and its downstream effectors (Right). GHRH also counteracts the increase in Epac1
  by PE through activation of PKA and inhibition of Epac1-induced hypertrophic pathways
  (Center). Cross-talk mechanisms between β1-AR/Gαs/Epac1 and α1-AR/Gq signaling are
  shown. “+” and “−” indicate stimulatory and inhibitory effects, respectively; interrupted
  lines indicate indirect effects. Abbreviations: Cn, calcineurin; DAG, diacylglycerol;
  Epac1, exchange protein directly activated by cAMP; GSK-3β, glycogen synthase kinase-3
  β; HDACs, class II histone deacetylases; IP3, inositol trisphosphate; MAPKs, mitogen-activated
  protein kinases; NFAT, nuclear factor of activated T cells; PLN(Ser16) phospholamban
  at serine 16; PLN(Thr17) phospholamban at threonine 17.'
papertitle: Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves
  heart function in pressure overload-induced heart failure.
reftext: Iacopo Gesmundo, et al. Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12033-12038.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9656851
figid_alias: PMC5692579__F4
figtype: Figure
redirect_from: /figures/PMC5692579__F4
ndex: d799bfec-ded1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5692579__pnas.1712612114fig04.html
  '@type': Dataset
  description: 'Signaling pathways involved in the antihypertrophic effects of GHRH
    in vitro. Antihypertrophic actions of GHRH include GHRH-R–dependent activation
    of the AC/cAMP/PKA pathway (Left). GHRH inhibits PE-induced signaling by blocking
    the α1-AR/Gq pathway and its downstream effectors (Right). GHRH also counteracts
    the increase in Epac1 by PE through activation of PKA and inhibition of Epac1-induced
    hypertrophic pathways (Center). Cross-talk mechanisms between β1-AR/Gαs/Epac1
    and α1-AR/Gq signaling are shown. “+” and “−” indicate stimulatory and inhibitory
    effects, respectively; interrupted lines indicate indirect effects. Abbreviations:
    Cn, calcineurin; DAG, diacylglycerol; Epac1, exchange protein directly activated
    by cAMP; GSK-3β, glycogen synthase kinase-3 β; HDACs, class II histone deacetylases;
    IP3, inositol trisphosphate; MAPKs, mitogen-activated protein kinases; NFAT, nuclear
    factor of activated T cells; PLN(Ser16) phospholamban at serine 16; PLN(Thr17)
    phospholamban at threonine 17.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ghrh
  - Gast
  - Gnas
  - Adora1
  - Ghrhr
  - ac
  - Plcb1
  - Rapgef3
  - Prkce
  - Camk2a
  - Camk2b
  - GHRH
  - ADRB1
  - GAST
  - GALNS
  - PAGR1
  - GHRHR
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PI3
  - RAPGEF3
  - RAPGEF4
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CAMK1
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - PRKCE
  - CAMK2G
  - Adrb1
  - Camk2d
  - Rgs19
  - Camk1
  - Nfat5
  - pe
  - gas
  - Galphas
  - gd
  - SK
  - norpA
  - Epac
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - CaMKI
  - cn
  - NFAT
  - CaMKII
---
